President Trump attacks symptom, not disease, in prescription drug price attack

  • The Hill | by: Robert M. Goldberg |
  • 07/10/2018 12:00 AM
by is licensed under
President Trump launched a new broadside against prescription drug manufacturers yesterday, tweeting, "Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend themselves."  

While it may be politically popular to blame drug prices for skyrocketing insurance costs, the president's claim doesn't stand up to scrutiny. Most notably, insurers don't pay list prices for the prescription drugs they put in their plan formularies.

They pay a deeply discounted rebate price negotiated by PBMs, which are middlemen between manufacturers and insurers. And these net prices have grown at less than the rate of the Consumer Price Index over recent years on a per capita basis.

Like Trump, health insurance executives also attribute rising health care costs to prescription drug prices. America’s Health Insurance Plans President Marilyn Tavenner and American Hospital Association President Rick Pollack wrote in an op-ed for The Hill: “Unjustified and unaccountable spikes in prescription drug prices are the engine of higher costs.”
 
 
 
 
Article Photo Credit: by is licensed under
Sign Up for Our Email Newsletter

RECENT NEWS

Drug shortages reaching record levels
  • Scripps News
  • 09/19/2023 12:00 AM

Drug shortages reaching record levels

Drug Shortages reaching record levels in the United States in nearly a decade...  Read more

When It Comes to FDA Communications

When It Comes to FDA Communications

Perhaps the most important lesson learned from the COVID-19 experience is that American health illiteracy kills....  Read more

Center for Medicine in the Public Interest Statement on ITC TRIPS Waiver Report
  • CMPI
  • 10/18/2023 12:00 AM

Center for Medicine in the Public Interest Statement on ITC TRIPS Waiver Report

Yesterday, the U.S. International Trade Commission published its report on possible expansion of the TRIPS waiver on Covi...  Read more

DRUGWONKS BLOG